A population based cohort study to monitor the safety and effectiveness of sirolimus in patients with sporadic lymphangioleiomyomatosis (S-LAM)

First published 08/07/2019

Last updated 23/04/2024

EU PAS number:

EUPAS30455

Study

Finalised

Download as PDF

Documents

Study protocol

Initial protocol

B1741224 NIS Protocol_Final_25 February 2019

English (423.23 KB - PDF) View document

Study results

Study results

b1741224-abstract

English (1.75 MB - PDF) View document

b1741224-report-body

English (4.05 MB - PDF) View document

Study report

Other information